Abstract
Purpose
To verify the reliability of HistoScanning™-based, true targeting (TT)-derived prostate biopsy.
Methods
We relied on 40 patients suspicious for prostate cancer who underwent standard and TT-derived prostate biopsy. Sensitivity, specificity, positive predictive value, negative predictive value and the area under the curve (AUC) were assessed for the prediction of biopsy results per octant by HistoScanning™, using different HistoScanning™ signal volume cutoffs (>0, >0.2 and >0.5 ml).
Results
Overall, 319 octants were analyzed. Of those, 64 (20.1 %) harbored prostate cancer. According to different HistoScanning™ signal volume cutoffs (>0, >0.2 and >0.5 ml), the AUCs for predicting biopsy results were: 0.51, 0.51 and 0.53, respectively. Similarly, the sensitivity, specificity, positive predictive and negative predictive values were: 20.7, 78.2, 17.4 and 81.6 %; 20.7, 82.0, 20.3 and 82.3 %; and 12.1, 94.6, 33.3 and 82.9 %, respectively.
Conclusions
Prediction of biopsy results based on HistoScanning™ signals and TT-derived biopsies was unreliable. Moreover, the AUC of TT-derived biopsies was low and did not improve when additional signal volume cutoffs were applied (>0.2 and >0.5 ml). We cannot recommend a variation of well-established biopsy standards or reduction in biopsy cores based on HistoScanning™ signals.
Similar content being viewed by others
References
Schiffmann J, Manka L, Boehm K, Leyh-Bannurah SR, Karakiewicz PI, Graefen M, Hammerer P, Salomon G (2015) Controversial evidence for the use of HistoScanning in the detection of prostate cancer. World J Urol. doi:10.1007/s00345-015-1555-y
Nunez-Mora C, Garcia-Mediero JM, Patino P, Orellana C, Garrido A, Rojo A, Rendon D (2013) Utility of Histoscanning prior to prostate biopsy for the diagnosis of prostate adenocarcinoma. Actas Urol Esp. doi:10.1016/j.acuro.2013.01.003
Schiffmann J, Tennstedt P, Fischer J, Tian Z, Beyer B, Boehm K, Sun M, Gandaglia G, Michl U, Graefen M, Salomon G (2014) Does HistoScanning predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate. World J Urol 32(4):925–930. doi:10.1007/s00345-014-1330-5
Javed S, Chadwick E, Edwards AA, Beveridge S, Laing R, Bott S, Eden C, Langley S (2013) Does HistoScanning play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int. doi:10.1111/bju.12568
Sivaraman A, Sanchez-Salas R, Barret E, Macek P, Validire P, Galiano M, Rozet F, Cathelineau X (2014) Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience. World J Urol. doi:10.1007/s00345-014-1434-y
Schiffmann J, Connan J, Salomon G, Boehm K, Beyer B, Schlomm T, Tennstedt P, Sauter G, Karakiewicz PI, Graefen M, Huland H (2015) Tumor volume in insignificant prostate cancer: increasing threshold gains increasing risk. Prostate 75(1):45–49. doi:10.1002/pros.22889
Braeckman J, Autier P, Garbar C, Marichal MP, Soviany C, Nir R, Nir D, Michielsen D, Bleiberg H, Egevad L, Emberton M (2008) Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 101(3):293–298. doi:10.1111/j.1464-410X.2007.07232.x
Braeckman J, Autier P, Soviany C, Nir R, Nir D, Michielsen D, Treurnicht K, Jarmulowicz M, Bleiberg H, Govindaraju S, Emberton M (2008) The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 102(11):1560–1565. doi:10.1111/j.1464-410X.2008.07878.x
Javed S, Chadwick E, Beveridge S, Bott S, Eden C, Langley S (2013) Does prostate Histoscanning™ accurately identify prostate cancer, measure tumour volume and assess pathological stage prior to radical prostatectomy? J Clin Urol. doi:10.1177/2051415813489682
Macek P, Barret E, Sanchez-Salas R, Galiano M, Rozet F, Ahallal Y, Gaya JM, Durant M, Mascle L, Giedelman C, Lunelli L, Validire P, Nesvadba M, Cathelineau X (2013) Prostate Histoscanning in clinically localized biopsy proven prostate cancer: an accuracy study. J Endourol. doi:10.1089/end.2013.0419
Schiffmann J, Fischer J, Tennstedt P, Beyer B, Bohm K, Michl U, Graefen M, Salomon G (2013) Comparison of prostate cancer volume measured by HistoScanning and final histopathological results. World J Urol. doi:10.1007/s00345-013-1211-3
Schiffmann J, Beyer B, Fischer J, Tennstedt P, Boehm K, Michl U, Graefen M, Salomon G (2014) Histoscanning has low sensitivity and specificity for seminal vesicle invasion. Urology 84(5):1168–1171. doi:10.1016/j.urology.2014.06.050
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest according to the current manuscript.
Ethical standard
The current manuscript has no conflict with ethical standards set by the Declaration of Helsinki.
Additional information
Jonas Schiffmann and Gisa Mehring have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Schiffmann, J., Mehring, G., Tennstedt, P. et al. True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts. World J Urol 34, 495–500 (2016). https://doi.org/10.1007/s00345-015-1637-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1637-x